logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (vii) All inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates6.544.428.111.95.22.30.90.721.5143992131
Cocaine7.948.423.410.35.22.71.30.921.31753494
Stimulants19.359.613.64.12.10.60.50.118.43983272
Hypnotics and sedatives14.227.715.012.47.77.45.510.026.01265367
Hallucinogens7.547.523.811.35.02.52.50.021.48091
Volatile substances36.046.89.93.22.60.60.30.617.634230
Cannabis 46.043.86.91.90.70.20.30.116.44549933
Other substances 26.531.616.911.27.32.71.22.621.11462792
Total16.645.320.88.94.22.01.01.020.3278335110
 

Notes:

Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LU,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table 109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012